Cribstone Capital Management buys $1,736,979 stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Cribstone Capital Management scooped up 503 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 18, 2016. The investment management firm now holds a total of 17,907 shares of CVS Health Corp which is valued at $1,736,979.CVS Health Corp makes up approximately 1.08% of Cribstone Capital Management’s portfolio.

Other Hedge Funds, Including , James Investment Research Inc reduced its stake in CVS by selling 6,070 shares or 4.74% in the most recent quarter. The Hedge Fund company now holds 121,871 shares of CVS which is valued at $11,805,644. CVS Health Corp makes up approx 0.29% of James Investment Research Inc’s portfolio.Hexavest boosted its stake in CVS in the latest quarter, The investment management firm added 245,677 additional shares and now holds a total of 621,928 shares of CVS Health Corp which is valued at $60,246,165. CVS Health Corp makes up approx 0.90% of Hexavest’s portfolio. Cue Financial Group added CVS to its portfolio by purchasing 4,170 company shares during the most recent quarter which is valued at $407,117. CVS Health Corp makes up approx 0.34% of Cue Financial Group’s portfolio.Moreno Evelyn V boosted its stake in CVS in the latest quarter, The investment management firm added 5,700 additional shares and now holds a total of 69,682 shares of CVS Health Corp which is valued at $6,741,037. CVS Health Corp makes up approx 2.52% of Moreno Evelyn V’s portfolio.

CVS Health Corp opened for trading at $97.26 and hit $97.37 on the upside on Wednesday, eventually ending the session at $97, with a gain of 0.10% or 0.1 points. The heightened volatility saw the trading volume jump to 34,85,961 shares. Company has a market cap of $104,180 M.

On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .Shares were Reiterated by Deutsche Bank on Jun 22, 2016 to “Hold” and Lowered the Price Target to $ 99 from a previous price target of $105 .CVS Health Corp was Downgraded by Morgan Stanley to ” Equal-Weight” on Jun 20, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.